Simple chalcones and bis-chalcones ethers as possible pleiotropic agents

References

• Hasan A, Khan KM, Sher M, et al. Synthesis and inhibitory potential towards acetylcholinesterase, butyrylcholinesterase and lipoxygenase of some variably substituted chalcones. J Enzyme Inhib Med Chem 2005;20:41–7
   PubMed Web of Science ®Google Scholar
• Katsori AM, Hadjipavlou-Litina D. Recent progress in therapeutic applications of chalcones. Exp Opin Ther Patents 2011;10:1575–96
   Web of Science ®Google Scholar
• Maurya DK, Devasagayam TP. Antioxidant and prooxidant nature of hydroxycinnamic acid derivatives ferulic and caffeic acid. Food Chem Toxicol 2010;48:3369–73
   PubMed Web of Science ®Google Scholar
• Ka MH, Choi EH, Chun HS, Lee KG. Antioxidative activity of volatile extracts isolated from Angelica tenuissimae roots, peppermint leaves, pine needles and sweet flag leaves. J Agric Food Chem 2005;53:4124–9
   PubMed Web of Science ®Google Scholar
• Molina-Jimenez MF, Sanchez-Reus MI, Andres D, et al. Neuroprotective effect of fraxetin and myricatin against rotenone-induced apoptosis in neuroblastoma cells. Brain Res 2004;1009:9–16
   PubMed Web of Science ®Google Scholar
• Labieniec M, Gabryelak T. Study of interactions between phenolic compounds and H2O2 or Cu(II) ions in B14 Chinese hamster cells. Cell Biol Intern 2006;30:761–8
   PubMed Web of Science ®Google Scholar
• McGeer EG, McGeer PL. Inflammatory processes in Alzheimer's disease. Progr Neuro-Physiopharm Biol Psych 2003;27:741–9
   PubMed Web of Science ®Google Scholar
• Garcia-Ayllon MS, Small DH, Avila J, Saez-Valero J. Revisiting the role of acetylcholinesterase in Alzheimer's disease: cross-talk with P-tau and β-amyloid. Front Mol Neurosci 2011;22:1–9
   Google Scholar
• Francis PT, Palmer AM, Snape M, Wilcock GKJ. The cholinergic hypothesis of Alzheimer's disease: a review of progress. Neuro Neurosurg Psychiatry 1999;66:137–47
   PubMed Web of Science ®Google Scholar
• Crooks SW, Stockley RA. Leukotriene B4. Int J Biochem Cell Biol 1998;30;173–8
   PubMed Web of Science ®Google Scholar
• Praticò D. Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol Sci 2008;29:609–15
   PubMed Web of Science ®Google Scholar
• Firuzi O, Zhuo J, Chinnici CM, et al. 5-Lipoxygenase gene disruption reduces amyloid-β pathology in a mouse model of Alzheimer's disease. FASEB J 2008;22:1169–78
   PubMed Web of Science ®Google Scholar
• Chu J, Li JG, Ceballos-Diaz C, et al. The influence of 5-lipoxygenase on Alzheimer's disease-related tau pathology: in vivo and in vitro evidence. Biol Psychiatry 2013;74;321–8
   PubMed Web of Science ®Google Scholar
• Brown D, Superti-Furga G. Rediscovering the sweet spot in drug discovery. Drug Discov Today 2003;8:1067–77
   PubMed Web of Science ®Google Scholar
• Szuromi P, Vinson V, Marshall E. Rethinking drug discovery. Introduction. Science 2004;303:1795–9
   Web of Science ®Google Scholar
• Overington JP, Al-Lazikani B, Hopkins AL. Opinion. How many drug targets are there? Nat Rev Drug Discov 2006;5:993–9
   PubMed Web of Science ®Google Scholar
• Mahreen A, Sugunadevi S, Guang Ping G, Keun WL. An innovative strategy for dual inhibitor design and its application in dual inhibition of human thymidylate synthase and dihydrofolate reductase enzymes. PLoS One 2013;8:e60470
   Google Scholar
• Csermely P, Agoston V, Pongor S. The efficiency of multi-target drugs: the network approach might help drug design. Trends Pharmacol Sci 2005;26:178–82
   PubMed Web of Science ®Google Scholar
• Cruciani G, Pastor M, Guba W. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci 2000;11:29–39
   PubMed Web of Science ®Google Scholar
• Ravi VM, Vidya J. Synthesis and insecticidal activity of new substituted phenoxychalcones. Indian J Chem 1995;34:56–457
   Google Scholar
• Vanangamudi G, Thirunarayanan G. Effects of substituents on IR deformation modes of vinyl system in 1-naphthyl ketones. Int J Chem Sci 2006;4:787–90
   Google Scholar
• Sodani RS, Choudhary PC, Sharma HO, Verma BL. Syntheses and reactions of 4′-[(w-Bromoalkyl)oxy]- and 4′,4‴-(Polymethylenedoxy)-bis substituted chalcones. Eur J Chem 2010;7:763–9
   Google Scholar
• Rekker R. The hydrophobic fragmental constant. Its derivation and application. A means of characterizing membrane systems. The Netherlands: Elsevier Eds Scientific Co.; 1977:1
   Google Scholar
• Biobyte Corp. C-QSAR Database 201. Claremont, CA. Available from: www.biobyte.com [last accessed June 2014]
   Google Scholar
• Pontiki E, D. Hadjipavlou-Litina D. Synthesis and pharmacochemical evaluation of novel aryl-acetic acid inhibitors of lipoxygenase, antioxidants, and anti-inflammatory agents. Bioorg Med Chem 2007;15:5819–27
   PubMed Web of Science ®Google Scholar
• Liégeois C, Lermusieau G, Collins SJ. Reducing powers of various hop varieties. Agric Food Chem 2000;48:1129–34
   PubMed Web of Science ®Google Scholar
• Dimmock JR, Kandepu NM, Hetherington M, et al. Cytotoxic activities of Mannich bases of chalcones and related compounds. J Med Chem 1998;41:1014–26
   PubMed Web of Science ®Google Scholar
• Ellman GL, Courtney KD, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharm 1961;7:88–95
   PubMed Web of Science ®Google Scholar
• Sybyl. Version 8.0. St. Louis, MO: TRIPOS Associates Inc.; 2008
   Google Scholar
• Vinter JG, Davis A, Saunders MR. Strategic approaches to drug design. I. An integrated software framework for molecular modeling. J Comput Aided Mol 1987;1:31–51
   PubMedGoogle Scholar
• Boyer S, Zamora I. New methods in predicting metabolism. J Comput Aided Mol 2002;16:403–13
   PubMed Web of Science ®Google Scholar
• Zamora I, Afzelius L, Cruciani G. Predicting drug metabolism: a site of metabolism prediction tool applied to the cytochrome P450 2C9. J Med Chem 2003;46:2313–24
   PubMed Web of Science ®Google Scholar
• Crivori P, Cruciani G, Carrupt PA, Testa B. Predicting blood–brain barrier permeation from three-dimensional molecular structure. J Med Chem 2000;43:2204–16
   PubMed Web of Science ®Google Scholar
• Cruciani G, Crivori P, Carrupt PA, Testa B. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach. J Mol Struct Theochem 2000;503:17–30
   Web of Science ®Google Scholar
• Dengler WA, Schulte J, Berger DP, et al. Development of a propidium iodide fluorescence assay for proliferation and cytotoxicity assays. Anti-Cancer Drugs 1995;6:522–32
   PubMed Web of Science ®Google Scholar
• Kulisic T, Radonic A, Katalinic V, Milos M. Use of different methods for testing antioxidative activity of oregano essential oil. Food Chem 2004;85:633–40
   Web of Science ®Google Scholar
• Koleva II, Van Beek TA, Linssen JPH, et al. Screening of plant extracts for antioxidant activity: a comparative study on three testing methods. Phytochem Anal 2001;13:8–17
   Web of Science ®Google Scholar
• Huang D, Ou B, Prior RL. The chemistry behind antioxidant capacity assays. J Agric Food Chem 2005;53:1841–56
   PubMed Web of Science ®Google Scholar
• Taraborewala RB, Kauffman JM. Synthesis and structure activity relationships of anti-inflammatory 9,10-dihydro-9-oxo-2-acridine – alkanoic acids and 4-(2-carboxyphenyl)aminobenzene alkanoic acids. J Pharm Sci 1990;79:173–8
   PubMed Web of Science ®Google Scholar
• Pontiki E, Hadjipavlou-Litina D. Lipoxygenase inhibitors: a comparative QSAR study review and evaluation of new QSARs. Med Res Rev 2008;28:39–117
   PubMed Web of Science ®Google Scholar
• Kang JE, Cho JK, Marcus J, et al. Inhibitory evaluation of sulfonamide chalcones on β-secretase and acylcholinesterase. Park Mol 2013;18:140–53
   Google Scholar
• Benvenuto JA, Connor TH, Monteith DK, et al. Degradation and inactivation of antitumor drugs. J Pharm Sci 1993;82:988–91
   PubMed Web of Science ®Google Scholar